talipexole has been researched along with Hyperprolactinaemia in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domae, M | 1 |
| Yamada, K | 1 |
| Hanabusa, Y | 1 |
| Matsumoto, S | 1 |
| Furukawa, T | 1 |
1 other study available for talipexole and Hyperprolactinaemia
| Article | Year |
|---|---|
Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
Topics: Animals; Azepines; Benzamides; Benzothiazoles; Dopamine Antagonists; Dose-Response Relationship, Dru | 1990 |